Vermont Tech Scene: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Vermont Tech Scene.

Press releases published on September 29, 2026

13 hours ago

Cellectar Biosciences to Present Compelling Efficacy Data from Phase 2 CLOVER WaM Subset Analysis of Iopofosine I 131 in Patients Refractory/Resistant to BTK Inhibitor Therapy at International Workshop for Waldenström Macroglobulinemia

Indeterminate GlobeNewswire

13 hours ago

Medicus Pharma Submits Optimized Teverelix® Registrational Protocol to FDA to Create Partner Ready Program in Advanced Prostate Cancer

Indeterminate GlobeNewswire

14 hours ago

TruGolf and Polymath to Present at The ThinkEquity Conference in New York on October 15

Indeterminate GlobeNewswire

14 hours ago

uniQure Announces Additional Data from Ongoing Phase I/II Studies of ifezuntirgene inilparvovec (AMT-130) in Huntington’s Disease Showing Continued Slowing of Disease Progression

Indeterminate GlobeNewswire

14 hours ago

Kraig Biocraft Laboratories Ships its First Commercial Spider Silk Yarn Order for Performance Sports Brand

Indeterminate GlobeNewswire

14 hours ago

Immix Biopharma Announces Pricing of $125 Million Underwritten Offering of Common Stock

Indeterminate GlobeNewswire

14 hours ago

Boehringer Ingelheim investments into sustainability-related programs and health partnerships to reach EUR 500 million

Indeterminate GlobeNewswire

14 hours ago

PolarityBio’s Phase 3 COVER DFUS II Trial Selected for First-to-Podium Presentation at SAWC Fall 2026

Indeterminate GlobeNewswire

14 hours ago

Ocugen to Participate in Upcoming October Investor and Industry Conferences

Indeterminate GlobeNewswire

14 hours ago

BeyondSpring Announces FDA Fast Track Designation for Plinabulin in Post-ICI Non-Squamous NSCLC and Strategic Transaction to Advance Global Phase 3 DUBLIN-4 Trial Toward Planned Interim Analysis

Indeterminate GlobeNewswire

14 hours ago

Invivyd Announces Positive Topline Results from LIBERTY Phase 3 Study Demonstrating VYD2311 Safety and Tolerability Superior to mRNA-based COVID-19 Vaccine; Announces Regulatory Submission Plans for VYD2311

Indeterminate GlobeNewswire

14 hours ago

EliseAI Raises $350 Million at $4 Billion Valuation to Bring AI Deeper Into Housing and Healthcare Operations

Indeterminate GlobeNewswire

14 hours ago

Aurora Mobile's GPTBots.ai Helps Ruko Cut Support Ticket Response Time from Two Hours to Under 10 Minutes

Indeterminate GlobeNewswire

14 hours ago

Cascade Prodrug Inc. Appoints Kenneth Mandell, M.D., Ph.D. to Board of Directors

Indeterminate GlobeNewswire

14 hours ago

Nurix Therapeutics Announces Achievement of $7 Million Milestone Under Strategic Collaboration with Pfizer

Indeterminate GlobeNewswire

14 hours ago

Aquestive Therapeutics Strengthens Board of Directors with Appointment of Richard Daly

Indeterminate GlobeNewswire

14 hours ago

Scintil Photonics Appoints Alexandru Romanescu as Vice President of Process Engineering

Indeterminate GlobeNewswire

14 hours ago

Iovance Biotherapeutics Raises Full Year 2026 Revenue Guidance to $410 to $420 Million

Indeterminate GlobeNewswire

14 hours ago

Xanadu and Bluefors Partner to Redefine Cryogenic Infrastructure for Utility-Scale Quantum Computing

Indeterminate GlobeNewswire

14 hours ago

Alpha Compute Update on Operating Oil and Gas Assets Due Diligence in Pennsylvania, Securing 300+ Acres Across the Marcellus and Utica Shales

Indeterminate GlobeNewswire